Nova Publishers
My Account Nova Publishers Shopping Cart
HomeBooksSeriesJournalsReference CollectionseBooksInformationSalesImprintsFor Authors
            
  Top » Catalog » Books » Biology » Proteins » Serpins and Protein Kinase Inhibitors: Novel Functions, Structural Features and Molecular Mechanisms Chapters » My Account  |  Cart Contents  |  Checkout   
Quick Find
  
Use keywords to find the product you are looking for.
Advanced Search
What's New? more
Fetal Alcohol Syndrome: Recognition, Differential Diagnosis and Long-Term Effects
$73.80
Shopping Cart more
0 items
Information
Shipping & Returns
Privacy Notice
Conditions of Use
Contact Us
Notifications more
NotificationsNotify me of updates to Protein Kinase Inhibitors: New Research pp.167-182
Tell A Friend
 
Tell someone you know about this product.
Protein Kinase Inhibitors: New Research pp.167-182 $100.00
Authors:  (Panagiotis Samaras, Frank Stenner - Department of Oncology, Univ. Hospital Zurich, Raemistrasse, Switzerland)
Abstract:
Treatment options for cancer have increased in the last years due to the ongoing research and development of new therapeutics. A focus shift from formerly undirected cytostatic agents to more targeted therapies, mainly antibodies and protein kinase inhibitors has taken place. New agents directed against receptors which control proliferation, migration and angiogenesis of tumor cells have been developed. Mainly specific antibodies directed against the extracellular ligand binding domain of various receptor tyrosine kinases, and protein kinase inhibitors targeting the intracellular protein kinase domain of receptors or cytoplasmic signalling proteins have been increasingly developed in the past years. In this chapter we will address the current treatment options with protein kinase inhibitors exemplarily for hepatocellular carcinoma and renal cell cancer. We will further give an insight into the actual research perspectives and the conception of incorporating new drugs into clinical trials as single agent treatment or combined with “classical” chemotherapy. The first part elucidates the molecular pathways of carcinogenesis and depicts the mode of action of these new agents in the treatment of hepatocellular carcinoma, the second part illustrates the pathogenesis of renal cell cancer and the resulting therapeutic options by targeting these pathways. 


Available Options:
Version:
This Item Is Currently Unavailable.
Special Focus Titles
01.Violent Communication and Bullying in Early Childhood Education
02.Cultural Considerations in Intervention with Women and Children Exposed to Intimate Partner Violence
03.Chronic Disease and Disability: The Pediatric Lung
04.Fruit and Vegetable Consumption and Health: New Research
05.Fire and the Sword: Understanding the Impact and Challenge of Organized Islamism. Volume 2

Nova Science Publishers
© Copyright 2004 - 2020

Protein Kinase Inhibitors: New Research pp.167-182